ipilimumab,nivolumab
bms
['ipi+', 'nivo', 'melanoma']
8/8 progressed on nivo alone, 1 lost the transplanted kidney as well. pd-1 alone was not sufficient! 2/6 patients responded to ipi+nivo. 2 had allograft loss. #melanoma #asco22 
Melanoma+Cell Therapy Oncologist @MSKCancerCenter| Cornell/DukeMed/ MGH IM/MSKCC Onc alum | FCOI: https://t.co/kwtet64Pe4